HLB3-002
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HLB3-002, covering 2025-07-01 to 2025-07-01. Get the full timeline:
Most recent: Clinical Trial Update: A Phase I Study to Evaluate the Safety and Drug Allergy of HLB3-002 in Healthy Volunteers [Phase 1]